CORCEPT THERAPEUTICS INC — Director's Dealing 2017

Mar 3, 2017

SEC Form 4/A — Form 4/A

Issuer: CORCEPT THERAPEUTICS INC (CORT)
CIK: 0001088856
Period of Report: 2016-11-09

Reporting Person: WILSON JAMES N (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-11-09	Common Stock	M	111349	$1.51	Acquired	111349	Direct
2016-11-09	Common Stock	S	111349	$8.3244	Disposed	0	Direct
2016-11-10	Common Stock	M	33247	$1.51	Acquired	33247	Direct
2016-11-10	Common Stock	S	33247	$8.9015	Disposed	0	Direct
2016-11-11	Common Stock	M	14216	$1.51	Acquired	14216	Direct
2016-11-11	Common Stock	S	14216	$9.1015	Disposed	0	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2016-11-09	Stock Option (Right to Buy)	$1.51	M	111349	Disposed	2017-05-18	Common Stock (111349)	Direct
2016-11-10	Stock Option (Right to Buy)	$1.51	M	33247	Disposed	2017-05-18	Common Stock (33247)	Direct
2016-11-11	Stock Option (Right to Buy)	$1.51	M	14216	Disposed	2017-05-18	Common Stock (14216)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	1571396	Indirect
Common Stock	901067	Indirect

Footnotes

F1: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $8.27 to $8.375 per share. Detailed information on the exact number of shares sold at each sale price can be obtained upon request.

F2: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $8.86 to $9.039 per share. Detailed information on the exact number of shares sold at each sale price can be obtained upon request.

F3: Represents the weighted average sale price for the entire number of shares sold. The actual sale prices range from $8.91 to $9.36 per share. Detailed information on the exact number of shares sold at each sale price can be obtained upon request.

F4: Fully Exercisable.